Howard P. Glauert

Articles in Scholarly Journals [Incomplete List]

  1. The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats
    Toxicology, vol. 239, no. 3, pp. 147–155, 2007
  2. Suppression of Peroxisomal Enzyme Activities and Cytochrome P450 4A Isozyme Expression by Congeneric Polybrominated and Polychlorinated Biphenyls
    PPAR Research, vol. 2007, Article ID 15481, 5 pages, 2007
  3. PCB 153, a Non-dioxin-like Tumor Promoter, Selects for  -Catenin (Catnb)-Mutated Mouse Liver Tumors
    Toxicological Sciences, vol. 93, no. 1, pp. 34–40, 2006
  4. Inhibition of Hepatocarcinogenesis by the Deletion of the p50 Subunit of NF-?B in Mice Administered the Peroxisome Proliferator Wy-14,643
    Toxicological Sciences, vol. 90, no. 2, pp. 331–336, 2005
  5. Research needs identified at the second PCB workshop in Brno, Czech Republic, May 7–11, 2002
    Toxicological and Environmental Chemistry, vol. 87, no. 3, pp. 261–265, 2005
  6. Role of Oxidative Stress in Peroxisome Proliferator-Mediated Carcinogenesis
    Critical Reviews in Toxicology, vol. 35, no. 1, pp. 61–88, 2005
  7. Comparison of different initiation protocols in the resistant hepatocyte model
    Toxicology, vol. 206, no. 3, pp. 373–381, 2005
  8. Effects of vitamin E on the NF-?B pathway in rats treated with the peroxisome proliferator, ciprofibrate
    Toxicology and Applied Pharmacology, vol. 199, no. 1, pp. 1–9, 2004
  9. Effect of 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB-153) on Hepatocyte Proliferation and Apoptosis in Mice Deficient in the p50 Subunit of the Transcription Factor NF- B
    Toxicological Sciences, vol. 81, no. 1, pp. 35–42, 2004
  10. Initiating Activity of 4-Chlorobiphenyl Metabolites in the Resistant Hepatocyte Model
    Toxicological Sciences, vol. 79, no. 1, pp. 41–46, 2004
  11. Cell Proliferation and Apoptosis Are Altered in Mice Deficient in the NF- B p50 Subunit after Treatment with the Peroxisome Proliferator Ciprofibrate
    Toxicological Sciences, vol. 75, no. 2, pp. 300–308, 2003
  12. Polychlorinated biphenyls as initiators in liver carcinogenesis: resistant hepatocyte model
    Toxicology and Applied Pharmacology, vol. 186, no. 1, pp. 55–62, 2003
  13. Effect of a single dose of polychlorinated biphenyls on hepatic cell proliferation and the DNA binding activity of NF-?B and AP-1 in rats
    Molecular Carcinogenesis, vol. 37, no. 4, pp. 171–180, 2003
  14. Regulation of Cell Proliferation, Apoptosis, and Transcription Factor Activities during the Promotion of Liver Carcinogenesis by Polychlorinated Biphenyls
    Toxicology and Applied Pharmacology, vol. 179, no. 3, pp. 172–184, 2002
  15. Effect of 3,3',4,4'-tetrachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl on the induction of hepatic lipid peroxidation and cytochrome P-450 associated enzyme activities in rats
    Toxicology, vol. 175, no. 1-3, pp. 15–25, 2002
  16. Peroxisome Proliferators Do Not Activate the Transcription Factors AP-1, Early Growth Response-1, or Heat Shock Factors 1 and 2 in Rats or Hamsters
    Toxicological Sciences, vol. 69, no. 1, pp. 139–148, 2002
  17. Effects of Peroxisome Proliferators on Antioxidant Enzymes and Antioxidant Vitamins in Rats and Hamsters
    Toxicological Sciences, vol. 60, no. 2, pp. 271–278, 2001
  18. Differential Activation of Hepatic NF-kappaB in Rats and Hamsters by the Peroxisome Proliferators Wy-14,643, Gemfibrozil, and Dibutyl Phthalate
    Toxicological Sciences, vol. 62, no. 1, pp. 20–27, 2001
  19. Polychlorinated Biphenyl-Induced Effects on Metabolic Enzymes, AP-1 Binding, Vitamin E, and Oxidative Stress in the Rat Liver
    Toxicology and Applied Pharmacology, vol. 171, no. 2, pp. 85–93, 2001
  20. Effects of Peroxisome Proliferators on Glutathione and Glutathione-Related Enzymes in Rats and Hamsters
    Toxicology and Applied Pharmacology, vol. 171, no. 1, pp. 27–37, 2001
  21. Peroxisome proliferator perfluorodecanoic acid alters glutathione and related enzymes
    Journal of Biochemical and Molecular Toxicology, vol. 15, no. 2, pp. 107–113, 2001
  22. Activation of nuclear factor-?B by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E
    Biochemical Pharmacology, vol. 59, no. 4, pp. 427–434, 2000
  23. Expression of the Hydrogen Peroxide-Generating Enzyme Fatty Acyl CoA Oxidase Activates NF-kappa B
    DNA and Cell Biology, vol. 19, no. 2, pp. 113–120, 2000
  24. Effect of extracellular matrix on the expression of peroxisome proliferation associated genes in cultured rat hepatocytes
    Toxicology in Vitro, vol. 14, no. 2, pp. 177–184, 2000
  25. Liver-specific catalase expression in transgenic mice inhibits NF- kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate
    Carcinogenesis, vol. 19, no. 4, pp. 631–637, 1998
  26. Effect of the Peroxisome Proliferator Ciprofibrate on Lipid Peroxidation and 8-Hydroxydeoxyguanosine Formation in Transgenic Mice with Elevated Hepatic Catalase Activity
    Free Radical Biology and Medicine, vol. 24, no. 9, pp. 1430–1436, 1998
  27. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats
    Toxicology, vol. 126, no. 1, pp. 65–73, 1998
  28. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes
    Toxicology, vol. 131, no. 2-3, pp. 99–107, 1998
  29. Activation of hepatic NF-?B by the herbicide Dicamba (2-methoxy-3,6-dichlorobenzoic acid) in female and male rats
    Journal of Biochemical and Molecular Toxicology, vol. 12, no. 6, pp. 339–344, 1998
  30. Inhibition of cigarette smoke-related lipophilic DNA adducts in rat tissues by dietary oltipraz
    Carcinogenesis, vol. 19, no. 8, pp. 1515–1517, 1998
  31. Interactions between carnosine and vitamin E in mammary cancer risk determination
    Nutrition Research, vol. 18, no. 4, pp. 723–733, 1998
  32. Effect of phenobarbital on hepatic eicosanoid concentrations in rats
    Archives of Toxicology, vol. 71, no. 10, pp. 646–650, 1997
  33. Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats
    Toxicology, vol. 123, no. 1-2, pp. 101–109, 1997
  34. Increased Liver-specific Expression of Catalase in Transgenic Mice
    Annals of the New York Academy of Sciences, vol. 804, no. 1 Peroxisomes, pp. 542–553, 1996
  35. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kB activity
    Carcinogenesis, vol. 17, no. 11, pp. 2305–2309, 1996
  36. Role of Eicosanoid Metabolism in Carcinogenesis by Peroxisome Proliferators
    Annals of the New York Academy of Sciences, vol. 804, no. 1 Peroxisomes, pp. 719–721, 1996
  37. Reduction of the concentrations of prostaglandins E2 and F2a, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate
    Toxicology Letters, vol. 85, no. 3, pp. 143–149, 1996
  38. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes
    Journal of Cellular Physiology, vol. 169, no. 2, pp. 309–319, 1996
  39. Activation of Hepatic NF-?B by Phenobarbital in Rats
    Biochemical and Biophysical Research Communications, vol. 229, no. 3, pp. 982–989, 1996
  40. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on ?-glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes
    Journal of Biochemical Toxicology, vol. 10, no. 5, pp. 239–243, 1995
  41. The Herbicide Dicamba (2-Methoxy-3,6-dichlorobenzoic Acid) Is a Peroxisome Proliferator in Rats
    Fundamental and Applied Toxicology, vol. 26, no. 1, pp. 85–90, 1995
  42. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid
    Archives of Toxicology, vol. 69, no. 7, pp. 491–497, 1995
  43. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid
    Cancer Letters, vol. 87, no. 2, pp. 223–228, 1994
  44. Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of two-stage hepatocarcinogenesis in rats
    Cancer Letters, vol. 72, no. 1-2, pp. 111–120, 1993
  45. Perfluorodecanoic Acid Noncompetitively Inhibits the Peroxisomal Enzymes Enoyl-CoA Hydratase and 3-Hydroxyacyl-CoA Dehydrogenase
    Toxicology and Applied Pharmacology, vol. 118, no. 1, pp. 8–15, 1993
  46. Polychlorinated and polybrominated biphenyl congeners and retinoid levels in rat tissues: Structure-activity relationships
    Toxicology and Applied Pharmacology, vol. 114, no. 1, pp. 47–55, 1992
  47. Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal ß-oxidation
    Archives of Toxicology, vol. 66, no. 1, pp. 18–22, 1992
  48. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats
    Biochemical Pharmacology, vol. 43, no. 6, pp. 1353–1359, 1992
  49. Screen of five alkyl carbamates for initiating and promoting activity in rat liver
    Cancer Letters, vol. 57, no. 1, pp. 37–44, 1991
  50. DO STRUCTURE-ACTIVITY RELATIONSHIPS FOR THE ACUTE TOXICITY OF PCBs AND PBBs ALSO APPLY FOR INDUCTION OF HEPATOCELLULAR CARCINOMA?
    Environmental Toxicology and Chemistry, vol. 10, no. 6, p. 715, 1991
  51. Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats
    Toxicology, vol. 62, no. 3, pp. 321–332, 1990
  52. Effect of the peroxisome proliferator perfluorodecanoic acid on growth and lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium
    Archives of Toxicology, vol. 64, no. 1, pp. 26–30, 1990
  53. Induction of peroxisomal enzymes in cultured porcine endothelial cells by the hypolipidemic drug ciprofibrate
    Journal of Biochemical Toxicology, vol. 5, no. 2, pp. 115–118, 1990
  54. Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate
    Journal of Cancer Research and Clinical Oncology, vol. 116, no. 4, pp. 351–356, 1990
  55. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis
    Cancer Letters, vol. 44, no. 2, pp. 95–100, 1989
  56. Effects of serum type on growth and permeability properties of cultured endothelial cells
    Experimental Cell Research, vol. 181, no. 2, pp. 589–596, 1989
  57. Effect of the antihistamine, methapyrilene, as an initiator of hepatocarcinogenesis in female rats
    Cancer Letters, vol. 46, no. 3, pp. 189–194, 1989
  58. Dose- and time-response of colon carcinogenesis in Fischer-344 rats after a single dose of 1,2-dimethylhydrazine
    Toxicology Letters, vol. 48, no. 3, pp. 283–287, 1989
  59. Dietary effects on initiation and promotion of hepatocarcinogenesis in rat
    Journal of Cancer Research and Clinical Oncology, vol. 114, no. 2, pp. 149–157, 1988
  60. The significance of selected biochemical markers in the characterization of putative initiated cell populations in rodent liver
    Cancer Letters, vol. 29, no. 1, pp. 1–14, 1985
  61. Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella
    Cancer Letters, vol. 24, no. 2, pp. 147–156, 1984
  62. Enhancement of 1,2-dimethylhydrazine-induced colon carcinogenesis in mice by dietary agar
    Food and Cosmetics Toxicology, vol. 19, pp. 281–286, 1981